ADMA Biologics, Inc. (ADMA) Free Cash Flow
ADMA Biologics, Inc. (ADMA) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2016-12-31 | -$18.34M |
| 2017-12-31 | -$41.74M |
| 2018-12-31 | -$64.77M |
| 2019-12-31 | -$82.77M |
| 2020-12-31 | -$114.73M |
| 2021-12-31 | -$125.88M |
| 2022-12-31 | -$73.42M |
| 2023-12-31 | $3.82M |
| 2024-12-31 | $110.10M |
| 2025-12-31 | $27.50M |
How ADMA compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| BRKR | Bruker Corporation | $43.30M |
| NEOG | Neogen Corporation | $31.90M |
| INNV | InnovAge Holding Corp. | $26.60M |
| VCEL | Vericel Corporation | $24.75M |
| TFX | Teleflex Incorporated | $1.45M |
These are five companies in the same sector as ADMA with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get ADMA Biologics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("ADMA", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ADMA | $9.63 | -2.08% | 0.71M |
| 3 | ||||
| 4 | ||||
| 5 |